Discontinuation of Sotazide.
Millar
R S
RS
D000889:Anti-Arrhythmia Agents / Q000600:supply & distribution* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000600:supply & distribution* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D000075202:Contraindications; D004338:Drug Combinations; D004345:Drug Industry; D004363:Drug Utilization; D006801:Humans; D006852:Hydrochlorothiazide / Q000600:supply & distribution* / Q000627:therapeutic use; D013015:Sotalol / Q000600:supply & distribution* / Q000627:therapeutic use; D013019:South Africa; D017180:Tachycardia, Ventricular / Q000139:chemically induced
D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D004338:Drug Combinations; D006852:Hydrochlorothiazide; D013015:Sotalol